查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1470992

口蹄疫疫苗市场：按产品、类型、应用和分销管道划分 - 全球预测 2024-2030 年

Foot & Mouth Disease Vaccines Market by Product (Conventional, Emergency), Type (DNA Vaccines, Inactivated Vaccines, Live Attenuated Vaccines), Application, Distribution Channel - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年口蹄疫疫苗市场规模为26.9亿美元，预计2024年将达29.3亿美元，2030年将达到49.5亿美元，复合年增长率为9.10%。

口蹄疫疫苗是生技药品，旨在引起牛、猪、绵羊和山羊等易感牲畜对口蹄疫病毒 (FMDV) 的免疫反应。疫苗含有灭活（杀死）的病毒或病毒的特定部分，可刺激动物的免疫系统产生抗体。如果动物接触到活病毒，这些抗体可以辨识并对抗活病毒。口蹄疫的全球流行和发病率、政府关于强制疫苗接种的政策和动物健康法规正在推动市场的成长。然而，新疫苗的核准过程和病毒株的变异使通用疫苗的开发变得复杂。然而，疫苗技术和製造方法的进步，以及政府对口蹄疫疫苗核准的扩大，预计将为口蹄疫疫苗市场创造成长机会。

主要市场统计
基准年[2023] 26.9亿美元
预测年份 [2024] 29.3亿美元
预测年份 [2030] 49.5亿美元
复合年增长率（%） 9.10%

产品 利用紧急疫苗快速解决意外的口蹄疫入侵激增

传统的口蹄疫（FMD）疫苗包括已使用数十年的灭活疫苗。这些疫苗由化学灭活的病毒组成，不会引起疾病，但会在接种疫苗的动物中产生免疫反应。传统疫苗被用作口蹄疫流行地区或有慢性疾病风险的地区的预防措施。在持续接触病毒的地区，传统疫苗是首选，可提供群体免疫并防止大规模爆发。这些疫苗在常规疫苗接种计划中向高风险族群接种。紧急疫苗是在疫情爆发或发现直接威胁时使用的。目的是快速诱导免疫力并阻止疾病传播。这些疫苗可以是相同的灭活疫苗。然而，这些疫苗已准备好快速部署，以尽量减少意外口蹄疫爆发的影响。当需要快速反应以遏制活跃的疫情爆发时，特别是在口蹄疫通常不发生的地区，需要紧急使用疫苗。此类紧急干预措施对于防止经济损失和防止感染传播到无疾病地区至关重要。

通路：兽医院分发口蹄疫疫苗

兽医院是口蹄疫疫苗的重要通路。这些设施与牲畜生产者密切合作，以保持牲畜健康并提供个人化护理和疫苗接种服务。兽医通常更喜欢能够快速增强免疫力的疫苗，以便他们的牲畜能够快速免受口蹄疫的侵害。另外，为了确保牲畜的健康，我们有时会选择副作用较少的疫苗。政府机构在口蹄疫 (FMD) 疫苗的分发中发挥着至关重要的作用。这些机构主要参与大规模免疫计划，以控制和消除疾病爆发。这些机构往往拥有大规模的购买力和广泛分发疫苗的能力，特别是在口蹄疫高风险地区。政府机构可能更喜欢已被证明非常有效并且可以提供较长时间免疫力的口蹄疫疫苗。

区域洞察

在消费者防止畜牧业经济损失的需求的推动下，亚太地区的口蹄疫疫苗市场显示出巨大的成长潜力。中国和印度等国家正在大力投资研究和技术以开发有效的疫苗，政府经常补贴费用以普及广泛接种疫苗。无口蹄疫地区，包括美洲，尤其是北美，正在投资口蹄疫疫苗，主要用于紧急准备。政府政策和国际贸易协定影响这些地区的购买行为，以维持无口蹄疫地区的生物安全。此外，市场需求以国家紧急储备制度下的紧急储备为主。虽然欧洲市场的预防措施已经成熟，但非洲和中东市场的驱动力是管理和缓解疫情的需要。欧洲、中东和非洲地区的消费者需求多样化，从欧洲先进的生物技术解决方案到非洲易于取得且具成本效益的疫苗。此外，随着对下一代疫苗的持续研究和投资，该地区的市场也取得了进展。口蹄疫在非洲流行，增加了对有效疫苗的需求。市场充满活力，许多国家依赖粮农组织和世界动物卫生组织等国际组织支持的疫苗接种宣传活动。

FPNV定位矩阵

FPNV 定位矩阵对于评估口蹄疫疫苗市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对口蹄疫疫苗市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.口蹄疫疫苗市场规模及预测如何？

2.口蹄疫疫苗市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？

3.口蹄疫疫苗市场的技术趋势和法规结构是什么？

4.口蹄疫疫苗市场主要厂商的市场占有率是多少？

5.进入口蹄疫疫苗市场的合适型态和策略性手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球口蹄疫的发生率和发生率均呈上升趋势
      • 政府是否有强制疫苗接种政策以促进动物健康？
    • 抑制因素
      • 对热不稳定性和短期免疫力的担忧
    • 机会
      • 增加研发投资，打造先进的口蹄疫疫苗
      • 政府对口蹄疫疫苗的核准增加
    • 任务
      • 与野生菌株重组的风险
  • 市场区隔分析
    • 产品：紧急疫苗的使用迅速增加，为意外疾病的入侵提供快速解决方案
    • 通路：兽医诊所分销口蹄疫疫苗的演变
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章 口蹄疫疫苗市场：副产品

  • 传统的
  • 紧急状况

第七章 口蹄疫疫苗市场：依类型

  • DNA疫苗
  • 灭活疫苗
  • 减毒活疫苗
  • 活性病毒载体疫苗
  • 胜胜肽疫苗

第八章 口蹄疫疫苗市场：依应用分类

  • 牛
  • 山羊
  • 猪
  • 羊

第九章 口蹄疫疫苗市场：依通路划分

  • 政府机关
  • 兽医诊所

第十章 美洲口蹄疫疫苗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区口蹄疫疫苗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东、非洲口蹄疫疫苗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 印度免疫学公司将在海德拉巴基因谷建造新的口蹄疫疫苗设施
    • Biogenesis Bago 在对抗口蹄疫方面取得了新的里程碑
    • 印尼开始在全国接种口蹄疫疫苗
  • 战略分析和建议

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-4316E4E8956A

[199 Pages Report] The Foot & Mouth Disease Vaccines Market size was estimated at USD 2.69 billion in 2023 and expected to reach USD 2.93 billion in 2024, at a CAGR 9.10% to reach USD 4.95 billion by 2030.

Foot and mouth disease vaccines are biologics designed to elicit an immunological response against the foot and mouth disease virus (FMDV) in susceptible livestock, such as cattle, swine, sheep, and goats. The vaccines contain inactivated (killed) viruses or specific parts of the virus, which stimulate the animal's immune system to produce antibodies. These antibodies can recognize and counteract the live virus if the animal is ever exposed to it, thereby preventing or reducing the severity of the disease. The prevalence and incidence of FMD outbreaks across the globe and government policies regarding mandatory vaccinations and animal health regulations increase market growth. However, stringent regulatory approval processes for new vaccines and variability in virus strains complicate the development of a universal vaccine. Nevertheless, advances in vaccine technology and production methodologies coupled with growing government approvals for FMD vaccines are expected to create growth opportunities for the foot and mouth disease vaccine market.

KEY MARKET STATISTICS
Base Year [2023] USD 2.69 billion
Estimated Year [2024] USD 2.93 billion
Forecast Year [2030] USD 4.95 billion
CAGR (%) 9.10%

Product: Burgeoning utilization of emergency vaccines offering a quick solution to unexpected incursions of the disease

Conventional vaccines for Foot & Mouth Disease (FMD) encompass inactivated vaccines that have been used for decades. These vaccines are composed of chemically inactivated viruses incapable of causing the disease; however, they evoke an immune response in vaccinated animals. Conventional vaccines are used as a preventive measure in regions where FMD is endemic or with a chronic disease risk. The preference for conventional vaccines is high in areas with continuous exposure to the virus, providing herd immunity and preventing widespread outbreaks. They are administered in regular vaccination programs to populations at risk. Emergency vaccines are used in the face of an outbreak or when an imminent threat is identified. They are designed to induce immunity rapidly and contain the spread of the disease. These vaccines may be of the same inactivated type. However, they are reserved for quick deployment to minimize the impact of unforeseen FMD outbreaks. The application of emergency vaccines is preferred when a rapid response is necessary to control an active outbreak, especially in areas where FMD is not usually present. This immediate intervention is critical to prevent economic losses and the potential spread to disease-free regions.

Distribution Channel: Evolving veterinary clinics for the distribution of foot and mouth disease vaccines

Veterinary clinics are significant channels for the distribution of FMD vaccines. These establishments work closely with livestock producers to maintain the health of the animals, offering individualized care and vaccination services. Veterinarians often prefer vaccines that offer rapid immunity build-up to ensure the livestock they treat are promptly protected against FMD. They may opt for vaccines with minimal side effects to ensure the livestock's well-being. Government Institutions are critical in distributing foot and mouth disease (FMD) vaccines. They are mainly involved in mass vaccination programs to control and eradicate disease outbreaks. These institutions often have large-scale purchasing power and the ability to distribute vaccines widely, especially in regions at high risk for FMD. Government bodies may prefer FMD vaccines that are proven to be highly effective and can confer immunity for a longer duration, which is vital for controlling the disease in endemic areas.

Regional Insights

The Asia-Pacific region demonstrates significant growth potential in the FMD vaccine market, driven by consumer needs to prevent economic losses in livestock production. Countries, including China and India, invest heavily in research and technology to develop effective vaccines, with governments often subsidizing costs to encourage widespread vaccination. The Americas, particularly the FMD-free zones, including North America, invest in FMD vaccines primarily for emergency preparedness. Government policy and international trade agreements influence purchasing behavior within these regions to maintain FMD-free status geared towards biosecurity. Furthermore, the market demand is centered on contingency stocks in alignment with the National Emergency Stockpile System. Europe's market is mature with preventative measures, while Africa and the Middle East are driven by the need to manage and mitigate outbreaks. Diverse consumer needs, from advanced biotechnological solutions in Europe to accessible and cost-effective African vaccines, characterize the EMEA region. Furthermore, the market here is advanced with ongoing research and investment in next-generation vaccines. Africa faces endemic FMD challenges, which amplifies the need for effective vaccines. The market is dynamic, with many countries reliant on vaccination campaigns supported by international organizations such as the FAO and OIE.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Foot & Mouth Disease Vaccines Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Foot & Mouth Disease Vaccines Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Foot & Mouth Disease Vaccines Market, highlighting leading vendors and their innovative profiles. These include Bharatbiotech International Ltd., Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Botswana Vaccine Institute, Brilliant Bio Pharma, Brilliant Bio Pharma Pvt. Ltd., China Animal Husbandry Group, Indian Immunologicals Ltd., Inner Mongolia Biwei Antai Biotechnology Co., Ltd., Inovio Pharmaceuticals, Inc., Jinyu Baoling Biopharmaceutical Co., Ltd., Laboratorios Bago S.A., Limor de Colombia, Merck KGaA, Merial S.A.S., MorphoSys AG, QYH Biotech Co., Ltd., Shenlian Biopharmaceutical (Shanghai) Co., Ltd., Vallee S.A., Vetal Animal Health Products S.A., and Veterinary Serum and Vaccine Research Institute.

Market Segmentation & Coverage

This research report categorizes the Foot & Mouth Disease Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Conventional
    • Emergency
  • Type
    • DNA Vaccines
    • Inactivated Vaccines
    • Live Attenuated Vaccines
    • Live Viral Vector Vaccines
    • Peptide Vaccines
  • Application
    • Cattle
    • Goat
    • Pigs
    • Sheep
  • Distribution Channel
    • Government Institutions
    • Veterinary Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Foot & Mouth Disease Vaccines Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Foot & Mouth Disease Vaccines Market?

3. What are the technology trends and regulatory frameworks in the Foot & Mouth Disease Vaccines Market?

4. What is the market share of the leading vendors in the Foot & Mouth Disease Vaccines Market?

5. Which modes and strategic moves are suitable for entering the Foot & Mouth Disease Vaccines Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence and incidence of FMD outbreaks across the globe
      • 5.1.1.2. Availability of government policies for mandatory vaccinations that promote animal health
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns related to thermal instability and short-lived immunity
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investments in R&D to yield advanced vaccines for FMD
      • 5.1.3.2. Growing government approvals for FMD vaccines
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of recombination with the wild strains
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Burgeoning utilization of emergency vaccines offering a quick solution to unexpected incursions of the disease
    • 5.2.2. Distribution Channel: Evolving veterinary clinics for the distribution of foot and mouth disease vaccines
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Foot & Mouth Disease Vaccines Market, by Product

  • 6.1. Introduction
  • 6.2. Conventional
  • 6.3. Emergency

7. Foot & Mouth Disease Vaccines Market, by Type

  • 7.1. Introduction
  • 7.2. DNA Vaccines
  • 7.3. Inactivated Vaccines
  • 7.4. Live Attenuated Vaccines
  • 7.5. Live Viral Vector Vaccines
  • 7.6. Peptide Vaccines

8. Foot & Mouth Disease Vaccines Market, by Application

  • 8.1. Introduction
  • 8.2. Cattle
  • 8.3. Goat
  • 8.4. Pigs
  • 8.5. Sheep

9. Foot & Mouth Disease Vaccines Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Government Institutions
  • 9.3. Veterinary Clinics

10. Americas Foot & Mouth Disease Vaccines Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Foot & Mouth Disease Vaccines Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Foot & Mouth Disease Vaccines Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Indian Immunologicals' new facility for FMD vaccines to come up in Hyderabad's Genome Valley
    • 13.3.2. Biogenesis Bago reaches a new milestone in its fight against Foot and Mouth Disease
    • 13.3.3. Indonesia launching nationwide vaccinations for foot and mouth disease
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. FOOT & MOUTH DISEASE VACCINES MARKET RESEARCH PROCESS
  • FIGURE 2. FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. FOOT & MOUTH DISEASE VACCINES MARKET DYNAMICS
  • FIGURE 7. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. FOOT & MOUTH DISEASE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. FOOT & MOUTH DISEASE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FOOT & MOUTH DISEASE VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY EMERGENCY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY EMERGENCY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY LIVE VIRAL VECTOR VACCINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY LIVE VIRAL VECTOR VACCINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PEPTIDE VACCINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PEPTIDE VACCINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CATTLE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CATTLE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY GOAT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY GOAT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PIGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PIGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY SHEEP, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY SHEEP, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY GOVERNMENT INSTITUTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY GOVERNMENT INSTITUTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 51. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 52. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 55. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 56. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 59. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 60. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 61. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 64. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 65. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 66. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 67. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 68. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 69. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 72. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 73. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 74. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 75. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 76. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 77. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 80. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 81. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 82. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 83. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 84. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 85. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 90. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 91. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 92. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 104. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 106. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 108. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 110. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 111. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 112. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 113. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 116. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 117. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 118. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 119. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 120. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 121. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 126. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 127. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 128. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 129. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 130. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 131. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 134. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 135. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 136. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 137. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 140. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 141. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 142. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 143. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 144. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 145. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 150. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 152. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 158. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 159. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 160. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 161. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 166. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 168. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 170. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 172. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 174. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 175. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 176. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 177. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 182. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 183. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 184. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 185. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 186. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 187. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 190. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 191. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 192. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 193. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 194. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 195. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 198. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 209. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 210. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 211. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 214. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 215. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 216. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 217. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 218. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 219. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 222. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 223. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 224. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 225. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 226. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 227. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 230. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 231. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 232. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 233. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 234. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 235. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 238. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 239. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 240. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 241. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 242. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 243. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 248. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 249. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 250. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 251. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 254. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 255. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 256. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 257. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 258. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 259. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 262. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 263. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 264. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 266. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 270. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 272. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 273. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 274. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 275. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 280. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 281. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 282. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 283. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 286. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 287. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 288. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 289. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 290. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 291. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 292. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 293. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 294. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 295. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 296. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 297. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 298. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 299. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 300. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 301. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 302. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 303. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 304. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 305. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 306. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 307. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 308. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 309. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 310. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 311. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 312. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 314. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 316. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 318. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 319. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET